Redding, California, May 22, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Direct-to-consumer (DTC) Laboratory Testing Market By Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), and Sample Type (Saliva, Urine, Blood) - Global Forecast to 2030,’ published by Meticulous Research®, the DTC Laboratory Testing Market is projected to reach $7.92 billion by 2030, at a CAGR of 10.9% during the forecast period 2023–2030.
Direct-to-consumer (DTC) laboratory tests are tests that are directly marketed to consumers without the involvement of healthcare professionals. The DTC laboratory testing market is mainly driven by increased consumer awareness regarding personal health management. Consumers can order a DTC lab test directly without consulting their healthcare provider and get results, allowing them to monitor & manage their health & wellness. Consumers favor these tests due to their many advantages, such as high affordability, convenience, and accessibility. Also, there is an ongoing shift from physician-driven healthcare toward consumer-driven healthcare.
Download Free Sample Report Now: https://www.meticulousresearch.com/download-sample-report/cp_id=5351
The growth of the direct-to-consumer laboratory testing market is driven by the increased awareness about personal health management, the benefits of DTC laboratory testing such as convenience, affordability, and accessibility, the increasing prevalence of chronic & infectious diseases, increasing healthcare costs, rising consumer awareness about ancestry/genealogy testing, and the rising elderly population. However, sample integrity and interference issues, regulatory concerns, the lack of reimbursements, and the lack of extensive test portfolios compared to conventional laboratory testing are restraining the growth of this market.
The growing adoption of telehealth, the rising popularity of DTC laboratory testing in emerging economies, and the increasing penetration of DTC pharmacogenomic testing are expected to generate growth opportunities for the players operating in this market. However, concerns regarding the security and privacy of genomic data, misinterpretation of test results, and the lack of professional medical counseling are major challenges to the growth of this market.
The COVID-19 Pandemic Accelerated the Growth and Awareness of DTC Laboratory Testing
The DTC testing laboratories provided self-test kits for consumers to test for COVID-19 and played a vital role in the fight against the pandemic. Several DTC laboratory testing companies focused on molecular and immunological tests for innovation in DTC testing, leading to the growth of the DTC laboratory testing market through the pandemic.
As self-isolation practices were adopted during the pandemic due to the risk of getting infected with the virus at testing centers and hospitals, there was an increased demand for easy-to-use rapid tests. This resulted in the development of antigen antibody-based tests. DTC laboratory testing market witnessed significant growth during the pandemic, which is expected to continue even after the pandemic because of the increasing prevalence of diseases and ease of accessibility to consumers.
Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5351
The report includes an extensive assessment of the market based on application, sample type, and geography. The study also provides valuable insights into the key growth strategies adopted by major market players in the last three to four years.
The DTC laboratory testing market is segmented based on application, sample type, and geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Based on application, in 2023, the genetic testing segment is expected to account for the largest share of the DTC laboratory testing market. The large market share of this segment is attributed to the rise in the appeal of DTC genetic testing to explore information regarding family health history and predictive testing, high curiosity among people in developed countries regarding their ancestry and lineage, and the launch of DTC genetic tests for new applications. For instance, in March 2022, Ancestory.com LLC (U.S.) launched introvert and extrovert test results in the reports. This test analyzes DNA factors responsible for being introverted and extroverted. Moreover, in March 2019, 23nadMe, Inc. (U.S.) launched its offering under which the company will provide a genetic health predisposition report on Type 2 diabetes.
Based on sample type, in 2023, the blood segment is expected to account for the largest share of the DTC laboratory testing market. Factors contributing to the large market share of this segment include the high convenience of at-home blood collection by phlebotomists, the availability of a wide range of tests for blood samples and the high reliability of the results obtained from blood samples.
Based on geography, in 2023, North America is expected to account for the largest share of the DTC laboratory testing market, followed by Europe, and Asia-Pacific. North America’s large market share is primarily attributed to increased consumer awareness about personal health management, high disposable income, and key market players in the region. However, Asia-Pacific is slated to register the highest CAGR during the forecast period. The factors driving the growth of the DTC laboratory testing market in Asia-Pacific are the increasing prevalence of infectious & chronic diseases and the increasing awareness in people regarding disease risk prediction and healthy lifestyle.
Quick Buy – DTC Laboratory Testing Market- Global Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/97746156
The DTC laboratory testing market has witnessed several product launches, enhancements, approvals, partnerships, collaboration & agreements, expansions, and acquisitions. For instance, in May 2022, Laboratory Corporation of America Holdings (U.S.) launched its Neurofilament Light Chain (NFL) blood test to identify and verify signs of neurodegenerative disease. Furthermore, in June 2020, Quest Diagnostics Incorporated (U.S.) received emergency use approval from the FDA for its Quest Diagnostics Self-collection Kit for COVID-19.
Some of the key players operating in this market are Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), 23andMe Holding Co. (U.S.), Myriad Genetics, Inc. (U.S.), Everlywell, Inc. (U.S.), DirectLabs, LLC. (U.S.), Ancestry.com, LLC (U.S.), MyMedLab, Inc. (U.S.), ANY LAB TEST NOW (U.S.), Thorne HealthTech, Inc. (U.S.), and LetsGetChecked, Inc. (U.S.).
Other than these, there are several regional players such as Color Health, Inc. (U.S), Laboratoire CERBA (France), MyHeritage Ltd. (Israel), Genova Diagnostics Inc. (U.S.), Gene by Gene, Ltd. (U.S.), Metropolis Healthcare Limited (India), Vitagene (U.S.), SRL Limited (India), Hirotsu Bio Science (Japan), Ambry Genetics Corporation (U.S.), Mapmygenome India Limited (India), FamilyTreeDNA (U.S.), Genera (Brazil), Veritas Intercontinental (Spain), Medichecks.com Ltd. (U.K.), EasyDNA (U.S.) (Subsidiary of Genetic Technologies Limited (Australia), Cerascreen Biotech LLC (U.K.), and Living DNA Ltd (U.K.).
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/direct-to-consumer-laboratory-testing-market-5351
Scope of the Report:
DTC Laboratory Testing Market, by Application
- Genetic Testing
- Ancestry/Genealogy
- Disease Risk Assessment
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Other Diseases
(Note: Disease risk assessment testing for other diseases includes celiac disease, alpha-1 antitrypsin deficiency, factor XI deficiency, glucose-6-phosphate dehydrogenase deficiency, etc.)
- Carrier Status
- Other Genetic Tests
(Note: The other genetic tests majorly include direct-to-consumer genetic testing for pharmacogenomics, skin care DNA tests, and nutrigenomic testing)
- Routine Clinical Testing
- Diabetes Testing
- COVID-19
- Sexually Transmitted Disease Testing
- Thyroid Function Testing
- Other Applications
(Note: The other applications segment comprises drug screening, infectious disease testing (Tuberculosis, Chicken Pox, Measles, Mumps, Rubella, UTI), allergy testing, fertility, pregnancy and nutritional testing)
DTC Laboratory Testing Market, by Sample Type
- Blood
- Saliva
- Urine
- Other Sample Types
(Note: The other sample types segment comprises stool, nasopharyngeal swab, vaginal swab, buccal swab, and semen)
DTC Laboratory Testing Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Request Free Sample Report Now: https://www.meticulousresearch.com/request-sample-report/cp_id=5351
Related Reports:
“In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030”
https://www.meticulousresearch.com/product/ivd-market-4858
Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Glucose, Infectious Diseases, Pregnancy, Drugs of Abuse), End User (Hospitals, Diagnostic Labs, Home Care) - Global Forecast to 2029
https://www.meticulousresearch.com/product/rapid-diagnostics-market-5240
In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) - Global Forecast to 2027
https://www.meticulousresearch.com/product/in-vitro-diagnostic-reagents-market-5110
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Blog: https://meticulousblog.org/top-10-companies-in-direct-to-consumer-laboratory-testing-market/
Content Source: https://www.meticulousresearch.com/pressrelease/577/direct-to-consumer-laboratory-testing-market-2030
